FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073054137> ?p ?o ?g. }

• W2073054137 endingPage "1791" @default.
• W2073054137 startingPage "1782" @default.
• W2073054137 abstract "Atherothrombosis is no longer considered solely a disorder of lipoprotein accumulation in the arterial wall. Rather, the initiation and progression of atherosclerotic lesions is currently understood to have major inflammatory influences that encompass components of both the innate and acquired immune systems. Promising clinical data for 'upstream' biomarkers of inflammation such as interleukin-6 (IL-6) as well as 'downstream' biomarkers such as C-reactive protein, observations regarding cholesterol crystals as an activator of the IL-1β generating inflammasome, and recent Mendelian randomization data for the IL-6 receptor support the hypothesis that inflammatory mediators of atherosclerosis may converge on the central IL-1, tumour necrosis factor (TNF-α), IL-6 signalling pathway. On this basis, emerging anti-inflammatory approaches to vascular protection can be categorized into two broad groups, those that target the central IL-6 inflammatory signalling pathway and those that do not. Large-scale Phase III trials are now underway with agents that lead to marked reductions in IL-6 and C-reactive protein (such as canakinumab and methotrexate) as well as with agents that impact on diverse non-IL-6-dependent pathways (such as varespladib and darapladib). Both approaches have the potential to benefit patients and reduce vascular events. However, care should be taken when interpreting these trials as outcomes for agents that target IL-6 signalling are unlikely to be informative for therapies that target alternative pathways, and vice versa. As the inflammatory system is redundant, compensatory, and crucial for survival, evaluation of risks as well as benefits must drive the development of agents in this class." @default.
• W2073054137 created "2016-06-24" @default.
• W2073054137 creator A5045293936 @default.
• W2073054137 creator A5091595592 @default.
• W2073054137 date "2014-05-26" @default.
• W2073054137 modified "2023-10-13" @default.
• W2073054137 title "Anti-inflammatory therapies for cardiovascular disease" @default.
• W2073054137 cites W110542923 @default.
• W2073054137 cites W1512569924 @default.
• W2073054137 cites W1586079541 @default.
• W2073054137 cites W1593008417 @default.
• W2073054137 cites W1964872560 @default.
• W2073054137 cites W1967323415 @default.
• W2073054137 cites W1967724716 @default.
• W2073054137 cites W1972483153 @default.
• W2073054137 cites W1974668849 @default.
• W2073054137 cites W1977848663 @default.
• W2073054137 cites W1984996259 @default.
• W2073054137 cites W1985705246 @default.
• W2073054137 cites W1989378033 @default.
• W2073054137 cites W1993662108 @default.
• W2073054137 cites W1995468535 @default.
• W2073054137 cites W2016531738 @default.
• W2073054137 cites W2017357456 @default.
• W2073054137 cites W2017754180 @default.
• W2073054137 cites W2020466729 @default.
• W2073054137 cites W2022621797 @default.
• W2073054137 cites W2024378513 @default.
• W2073054137 cites W2024990134 @default.
• W2073054137 cites W2028420196 @default.
• W2073054137 cites W2028545985 @default.
• W2073054137 cites W2031980199 @default.
• W2073054137 cites W2032374475 @default.
• W2073054137 cites W2032972268 @default.
• W2073054137 cites W2033896075 @default.
• W2073054137 cites W2040815013 @default.
• W2073054137 cites W2042227371 @default.
• W2073054137 cites W2043769111 @default.
• W2073054137 cites W2045771190 @default.
• W2073054137 cites W2050449334 @default.
• W2073054137 cites W2055678219 @default.
• W2073054137 cites W2060790359 @default.
• W2073054137 cites W2061870298 @default.
• W2073054137 cites W2063612356 @default.
• W2073054137 cites W2067504868 @default.
• W2073054137 cites W2070396041 @default.
• W2073054137 cites W2073864769 @default.
• W2073054137 cites W2074115529 @default.
• W2073054137 cites W2074430079 @default.
• W2073054137 cites W2079926187 @default.
• W2073054137 cites W2086757832 @default.
• W2073054137 cites W2090578197 @default.
• W2073054137 cites W2093395086 @default.
• W2073054137 cites W2095507444 @default.
• W2073054137 cites W2099806958 @default.
• W2073054137 cites W2101363646 @default.
• W2073054137 cites W2102935782 @default.
• W2073054137 cites W2104388295 @default.
• W2073054137 cites W2105328088 @default.
• W2073054137 cites W2107937036 @default.
• W2073054137 cites W2109064884 @default.
• W2073054137 cites W2109138478 @default.
• W2073054137 cites W2109150493 @default.
• W2073054137 cites W2110551379 @default.
• W2073054137 cites W2113275926 @default.
• W2073054137 cites W2113978145 @default.
• W2073054137 cites W2114022169 @default.
• W2073054137 cites W2114408062 @default.
• W2073054137 cites W2118825330 @default.
• W2073054137 cites W2118964113 @default.
• W2073054137 cites W2124783878 @default.
• W2073054137 cites W2124964328 @default.
• W2073054137 cites W2126384096 @default.
• W2073054137 cites W2128313682 @default.
• W2073054137 cites W2128876187 @default.
• W2073054137 cites W2128901862 @default.
• W2073054137 cites W2131615550 @default.
• W2073054137 cites W2131872763 @default.
• W2073054137 cites W2131985274 @default.
• W2073054137 cites W2133101212 @default.
• W2073054137 cites W2137983259 @default.
• W2073054137 cites W2138809584 @default.
• W2073054137 cites W2139957955 @default.
• W2073054137 cites W2141618138 @default.
• W2073054137 cites W2143727405 @default.
• W2073054137 cites W2144896295 @default.
• W2073054137 cites W2145053304 @default.
• W2073054137 cites W2146461935 @default.
• W2073054137 cites W2147155927 @default.
• W2073054137 cites W2147758955 @default.
• W2073054137 cites W2147779949 @default.
• W2073054137 cites W2150367899 @default.
• W2073054137 cites W2151223394 @default.
• W2073054137 cites W2151280392 @default.
• W2073054137 cites W2151729372 @default.
• W2073054137 cites W2155123856 @default.
• W2073054137 cites W2157157967 @default.
• W2073054137 cites W2158057499 @default.

• next